SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis

Biological Psychiatry

Volumn 77, Issue 6, 2015, Pages 526-536

  Larhammar, Martin ^a   Patra, Kalicharan ^a   Blunder, Martina ^a   Emilsson, Lina ^a   Peuckert, Christiane ^a   Arvidsson, Emma ^a   Rönnlund, Daniel ^b   Preobraschenski, Julia ^c   Birgner, Carolina ^a   Limbach, Christoph ^a   Widengren, Jerker ^b   Blom, Hans ^b   Jahn, Reinhard ^c   Wallén Mackenzie, Åsa ^a   Kullander, Klas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Acetylcholine; Amphetamine; Central nervous system; Cocaine; Noradrenaline; Serotonin; Synaptic transmission; Transmitter

Indexed keywords

AMPHETAMINE; DOPAMINE; NORADRENALIN; SEROTONIN; TRANSPORTER PROTEIN; TRANSPORTER PROTEIN SLC10A4; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VESICULAR AMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; MESSENGER RNA; MONOAMINE OXIDASE INHIBITOR; NERVE PROTEIN; SLC10A4 PROTEIN, MOUSE; SLC18A2 PROTEIN, MOUSE; SLC18A3 PROTEIN, MOUSE; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER; VESICULAR TRANSPORT PROTEIN;

AMPEROMETRY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOWN REGULATION; HOMEOSTASIS; MOUSE; NEUROMODULATION; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SEROTONIN BRAIN LEVEL; SYNAPSE VESICLE; ANIMAL; BRAIN; DRUG EFFECTS; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SPINAL CORD; TRANSGENIC MOUSE;

AMPHETAMINE; ANIMALS; BRAIN; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HOMEOSTASIS; MICE, TRANSGENIC; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NOREPINEPHRINE; RNA, MESSENGER; SEROTONIN; SPINAL CORD; SYNAPTIC VESICLES; TRANYLCYPROMINE; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 84922930996     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.07.017     Document Type: Article

References (61)

1. K. Fuxe, A. Dahlstrom, M. Hoistad, D. Marcellino, A. Jansson, and A. Rivera From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission Brain Res Rev 55 2007 17 54
2. P.R. Lewis, and C.C. Shute The distribution of cholinesterase in cholinergic neurons demonstrated with the electron microscope J Cell Sci 1 1966 381 390
3. K.S. Eriksson, O.A. Sergeeva, H.L. Haas, and O. Selbach Orexins/hypocretins and aminergic systems Acta Physiol (Oxf) 198 2010 263 275
4. J. Kollonitsch, L.M. Perkins, A.A. Patchett, G.A. Doldouras, S. Marburg, and D.E. Duggan Selective inhibitors of biosynthesis of aminergic neurotransmitters Nature 274 1978 906 908
5. J.J. Mann, M. Stanley, S. Gershon, and M. Rossor Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion Science 210 1980 1369 1371
6. L.E. Eiden, M.K. Schafer, E. Weihe, and B. Schutz The vesicular amine transporter family (SLC18): Amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine Pflugers Arch 447 2004 636 640
7. A. Alfonso, K. Grundahl, J.S. Duerr, H.P. Han, and J.B. Rand The Caenorhabditis elegans unc-17 gene: A putative vesicular acetylcholine transporter Science 261 1993 617 619
8. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol Rev 63 2011 182 217
9. F.X. Castellanos, and R. Tannock Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes Nat Rev Neurosci 3 2002 617 628
10. J. Geyer, T. Wilke, and E. Petzinger The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships Naunyn Schmiedebergs Arch Pharmacol 372 2006 413 431
11. A. Enjin, N. Rabe, S.T. Nakanishi, A. Vallstedt, H. Gezelius, and F. Memic Identification of novel spinal cholinergic genetic subtypes disclose Chodl and Pitx2 as markers for fast motor neurons and partition cells J Comp Neurol 518 2010 2284 2304
12. J. Geyer, C.F. Fernandes, B. Doring, S. Burger, J.R. Godoy, and S. Rafalzik Cloning and molecular characterization of the orphan carrier protein Slc10a4: Expression in cholinergic neurons of the rat central nervous system Neuroscience 152 2008 990 1005
13. T. Abe, Y. Kanemitu, M. Nakasone, I. Kawahata, T. Yamakuni, and A. Nakajima SLC10A4 is a protease-activated transporter that transports bile acids J Biochem 154 2013 93 101
14. J. Zelano, S. Mikulovic, K. Patra, M. Kuhnemund, M. Larhammar, and L. Emilsson The synaptic protein encoded by the gene Slc10A4 suppresses epileptiform activity and regulates sensitivity to cholinergic chemoconvulsants Exp Neurol 239 2013 73 81
15. S. Burger, B. Doring, M. Hardt, K. Beuerlein, R. Gerstberger, and J. Geyer Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system Neuroscience 193 2011 109 121
16. S. Burger, B. Döring, M. Hardt, K. Beuerlein, R. Gerstberger, and J. Geyer Co-expression studies of the orphan carrier protein SLC10A4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system [published correction appears in Neuroscience 2012;212:226] Neuroscience 193 2011 109 121
17. M.J. Nirenberg, Y. Liu, D. Peter, R.H. Edwards, and V.M. Pickel The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei Proc Natl Acad Sci U S A 92 1995 8773 8777
18. J. Ren, C. Qin, F. Hu, J. Tan, L. Qiu, and S. Zhao Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes Neuron 69 2011 445 452
19. A. Jeremic, W.J. Cho, and B.P. Jena Involvement of water channels in synaptic vesicle swelling Exp Biol Med (Maywood) 230 2005 674 680
20. S. Fredriksson, M. Gullberg, J. Jarvius, C. Olsson, K. Pietras, and S.M. Gustafsdottir Protein detection using proximity-dependent DNA ligation assays Nat Biotechnol 20 2002 473 477
21. B.J. Meyerson, H. Augustsson, M. Berg, and E. Roman The Concentric Square Field: A multivariate test arena for analysis of explorative strategies Behav Brain Res 168 2006 100 113
22. A. Wallen-Mackenzie, K. Nordenankar, K. Fejgin, M.C. Lagerstrom, L. Emilsson, and R. Fredriksson Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function J Neurosci 29 2009 2238 2251
23. J.W. Commissiong Monoamine metabolites: Their relationship and lack of relationship to monoaminergic neuronal activity Biochem Pharmacol 34 1985 1127 1131
24. H. Cransac, J.M. Cottet-Emard, J.M. Pequignot, and L. Peyrin Monoamines (norepinephrine, dopamine, serotonin) in the rat medial vestibular nucleus: Endogenous levels and turnover J Neural Transm 103 1996 391 401
25. P.J. Karstaedt, H. Kerasidis, J.H. Pincus, R. Meloni, J. Graham, and K. Gale Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats Exp Neurol 126 1994 25 30
26. T. Sharp, T. Zetterstrom, H.G. Series, A. Carlsson, D.G. Grahame-Smith, and U. Ungerstedt HPLC-EC analysis of catechols and indoles in rat brain dialysates Life Sci 41 1987 869 872
27. P.L. Splinter, K.N. Lazaridis, P.A. Dawson, and N.F. LaRusso Cloning and expression of SLC10A4, a putative organic anion transport protein World J Gastroenterol 12 2006 6797 6805
28. C.J. Wilhelm, R.A. Johnson, P.G. Lysko, A.J. Eshleman, and A. Janowsky Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system J Pharmacol Exp Ther 310 2004 1142 1151
29. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
30. P.R. Maycox, T. Deckwerth, J.W. Hell, and R. Jahn Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes J Biol Chem 263 1988 15423 15428
31. D. Sulzer, M.S. Sonders, N.W. Poulsen, and A. Galli Mechanisms of neurotransmitter release by amphetamines: A review Prog Neurobiol 75 2005 406 433
32. D. Peter, J. Jimenez, Y. Liu, J. Kim, and R.H. Edwards The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors J Biol Chem 269 1994 7231 7237
33. A. Carlsson, N.A. Hillarp, and B. Waldeck Analysis of the Mg++-Atp dependent storage mechanism in the amine granules of the adrenal medulla Acta Physiol Scand Suppl 215 1963 1 38
34. R.G. Johnson Jr. Accumulation of biological amines into chromaffin granules: A model for hormone and neurotransmitter transport Physiol Rev 68 1988 232 307
35. R.I. Desai, P. Terry, and J.L. Katz A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice Pharmacol Biochem Behav 81 2005 843 848
36. R.M. Sullivan, H. Talangbayan, H. Einat, and H. Szechtman Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats Neuroscience 83 1998 781 789
37. A.S. Villegier, L. Salomon, G. Blanc, G. Godeheu, J. Glowinski, and J.P. Tassin Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice Eur J Neurosci 24 2006 1359 1365
38. E.A. Fon, E.N. Pothos, B.C. Sun, N. Killeen, D. Sulzer, and R.H. Edwards Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action Neuron 19 1997 1271 1283
39. Y.M. Wang, R.R. Gainetdinov, F. Fumagalli, F. Xu, S.R. Jones, and C.B. Bock Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine Neuron 19 1997 1285 1296
40. N. Takahashi, L.L. Miner, I. Sora, H. Ujike, R.S. Revay, and V. Kostic VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity Proc Natl Acad Sci U S A 94 1997 9938 9943
41. K.A. Mooslehner, P.M. Chan, W. Xu, L. Liu, C. Smadja, and T. Humby Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: Potential mouse model for parkinsonism Mol Cell Biol 21 2001 5321 5331
42. D.S. Kim, M.S. Szczypka, and R.D. Palmiter Dopamine-deficient mice are hypersensitive to dopamine receptor agonists J Neurosci 20 2000 4405 4413
43. J.M. Brown, G.R. Hanson, and A.E. Fleckenstein Cocaine-induced increases in vesicular dopamine uptake: Role of dopamine receptors J Pharmacol Exp Ther 298 2001 1150 1153
44. J. Patel, K.A. Mooslehner, P.M. Chan, P.C. Emson, and J.A. Stamford Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice J Neurochem 85 2003 898 910
45. A. Carlsson Drugs acting through dopamine release Pharmacol Ther B 1 1975 401 405
46. W. Kehr, A. Carlsson, M. Lindqvist, T. Magnusson, and C. Atack Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity J Pharm Pharmacol 24 1972 744 747
47. B.I. Kanner, and S. Schuldiner Mechanism of transport and storage of neurotransmitters CRC Crit Rev Biochem 22 1987 1 38
48. J. Cooper, F. Bloom, and R. Roth The Biochemical Basis of Neuropharmacology 2003 Oxford University Press New York
49. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc Natl Acad Sci U S A 95 1998 4029 4034
50. F.A. Chaudhry, J.L. Boulland, M. Jenstad, M.K. Bredahl, and R.H. Edwards Pharmacology of neurotransmitter transport into secretory vesicles Handb Exp Pharmacol 2008 77 106
51. S.M. Stobrawa, T. Breiderhoff, S. Takamori, D. Engel, M. Schweizer, and A.A. Zdebik Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus Neuron 29 2001 185 196
52. S. Schenck, S.M. Wojcik, N. Brose, and S. Takamori A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles Nat Neurosci 12 2009 156 162
53. B. Amilhon, E. Lepicard, T. Renoir, R. Mongeau, D. Popa, and O. Poirel VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety J Neurosci 30 2010 2198 2210
54. C. Gras, B. Amilhon, E.M. Lepicard, O. Poirel, J. Vinatier, and M. Herbin The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone Nat Neurosci 11 2008 292 300
55. L.A. Bankston, and G. Guidotti Characterization of ATP transport into chromaffin granule ghosts. Synergy of ATP and serotonin accumulation in chromaffin granule ghosts J Biol Chem 271 1996 17132 17138
56. O. Scheel, A.A. Zdebik, S. Lourdel, and T.J. Jentsch Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins Nature 436 2005 424 427
57. D. Scherman, and J.P. Henry Role of the proton electrochemical gradient in monoamine transport by bovine chromaffin granules Biochim Biophys Acta 601 1980 664 677
58. T. Claro da Silva, J.E. Polli, and P.W. Swaan The solute carrier family 10 (SLC10): Beyond bile acid transport Mol Aspects Med 34 2013 252 269
59. M. Laruelle, L.S. Kegeles, and A. Abi-Dargham Glutamate, dopamine, and schizophrenia: From pathophysiology to treatment Ann N Y Acad Sci 1003 2003 138 158
60. S.N. Popova, and I. Alafuzoff Distribution of SLC10A4, a synaptic vesicle protein in the human brain, and the association of this protein with Alzheimer's disease-related neuronal degeneration J Alzheimers Dis 37 2013 603 610
61. K. Borges Slc10A4 - what do we know about the function of this "secret ligand carrier" protein? Exp Neurol 248C 2013 258 261